FDA Inspection 1307066 — Danbury Hospital, BB

Danbury Hospital, BB — FEI 1272269

The FDA completed an inspection of Danbury Hospital, BB on February 26, 2026 in Danbury, CT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 26, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Danbury, CT (United States)